1. Zhu, Shimiao, Yang, Zhao, Zhang, Zheng, Quan, Changyi, Niu, Yuanjie. 2023. HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. In Cell death & disease, 14, 215. doi:10.1038/s41419-023-05742-y. https://pubmed.ncbi.nlm.nih.gov/36973255/
2. Yin, Chunlai, Li, Yanqi, Zhang, Cheng, Li, Xia, Li, Weiping. 2024. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease. In BMC cancer, 24, 111. doi:10.1186/s12885-024-11859-w. https://pubmed.ncbi.nlm.nih.gov/38254070/
3. Kwan, C T, Tsang, S L, Krumlauf, R, Sham, M H. . Regulatory analysis of the mouse Hoxb3 gene: multiple elements work in concert to direct temporal and spatial patterns of expression. In Developmental biology, 232, 176-90. doi:. https://pubmed.ncbi.nlm.nih.gov/11254356/
4. Zhao, Laigang, Yang, HanLin, Wang, Yuanmei, Zhao, Xing, Zi, Dan. 2024. STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression. In Communications biology, 7, 1439. doi:10.1038/s42003-024-07127-z. https://pubmed.ncbi.nlm.nih.gov/39501077/
5. Miller, Katherine R, Patel, Jai N, Zhang, Qing, Tait, David L, Ganapathi, Mahrukh K. . HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy. In Gynecologic oncology, 149, 155-162. doi:10.1016/j.ygyno.2018.01.022. https://pubmed.ncbi.nlm.nih.gov/29402501/
6. Zhu, Lizhe, Yu, Shibo, Jiang, Siyuan, Ren, Yu, Wang, Bin. 2020. Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer. In PeerJ, 8, e10421. doi:10.7717/peerj.10421. https://pubmed.ncbi.nlm.nih.gov/33240685/
7. Agostini, Antonio, Piro, Geny, Inzani, Frediano, Tortora, Giampaolo, Carbone, Carmine. 2024. Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms. In Nature communications, 15, 2764. doi:10.1038/s41467-024-46994-2. https://pubmed.ncbi.nlm.nih.gov/38553466/
8. Palakurthy, Rajendra Kumar, Wajapeyee, Narendra, Santra, Manas K, Gobeil, Stephane, Green, Michael R. . Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. In Molecular cell, 36, 219-30. doi:10.1016/j.molcel.2009.10.009. https://pubmed.ncbi.nlm.nih.gov/19854132/
9. Wong, Elaine Y M, Wang, Xing An, Mak, Siu Shan, Fritzsch, Bernd, Sham, Mai Har. 2011. Hoxb3 negatively regulates Hoxb1 expression in mouse hindbrain patterning. In Developmental biology, 352, 382-92. doi:10.1016/j.ydbio.2011.02.003. https://pubmed.ncbi.nlm.nih.gov/21320481/
10. Yan, Ming, Yin, Xiaojun, Zhang, Luan, Cui, Yuanbo, Ma, Xiwen. 2022. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma. In Molecular biology reports, 49, 2607-2618. doi:10.1007/s11033-021-07064-8. https://pubmed.ncbi.nlm.nih.gov/35028857/